Preoperative Stomach Cancer Induction Chemotherapy and Radiation Therapy — President

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Locally Advanced Gastric Carcinoma Clinical Trial

Official title:
A Phase III Trial of Preoperative or Postoperative Chemoradiation Therapy for Potentially Resectable Adenocarcinoma of Stomach Cancer

Status Recruiting

Clinical Trial Summary

Based upon RTOG 9904, this study is to investigate the role of preoperative chemo and chemoradiation for locally advanced gastric cancer.

n/a

NCT number	NCT03223740
Study type	Interventional
Source	Sichuan Provincial People's Hospital
Contact	Qian Peng, MD PhD
Phone	008617708130617
Email	pengqian0522@163.com
Status	Recruiting
Phase	Phase 3
Start date	September 2016
Completion date	October 2021

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06284746` - Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer	Phase 2
Recruiting	`NCT04891016` - Toripalimab Plus FLOT in Locally Advanced Gastric Cancer	Phase 2
Recruiting	`NCT06396143` - Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration
Completed	`NCT02048540` - Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell	Phase 1/Phase 2
Not yet recruiting	`NCT06364410` - Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors	Phase 1
Recruiting	`NCT04550494` - Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations	Phase 2
Recruiting	`NCT05593458` - Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1	Phase 3